Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA
Authors:
- Changdong ZhouCZChangdong Zhou
- Junlian GuJGJunlian Gu
- Yanan LiuYLYanan Liu
- Lijing ZhaoLZLijing Zhao
- Wei LiWLWei Li
- Guanjun WangGWGuanjun Wang
- Yang LiYLYang Li
- Lu CaiLCLu Cai
- 1 August 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 337 (1) , 133-142
Abstract
No abstract availableKeywords
Funding Information
- Research Fund for the Scientific
This publication has 44 references indexed in Scilit:
- Cost‐effectiveness of prostate cancer chemopreventionCancer, 2008
- Response to docetaxel/carboplatin‐based chemotherapy as first‐ and second‐line therapy in patients with metastatic hormone‐refractory prostate cancerBJU International, 2008
- A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone‐refractory prostate cancer who are refractory to docetaxelCancer, 2007
- A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study AnalysisClinical Cancer Research, 2007
- Improved Stage and Grade-Specific Progression-Free Survival Rates After Radical Prostatectomy in the PSA EraUrology, 2007
- Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of MelanomaCancer Research, 2007
- Current Indications for Chemotherapy in Prostate Cancer PatientsEuropean Urology, 2007
- Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate CancerClinical Genitourinary Cancer, 2005
- Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patientsExpert Opinion on Drug Safety, 2005
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal of Cancer, 1998